Quantcast

Latest Rosetta Genomics Stories

2011-05-09 07:33:00

PHILADELPHIA and REHOVOT, Israel, May 9, 2011 /PRNewswire/ -- Rosetta Genomics (NASDAQ: ROSG) today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,943,745, which is related to human hsa-miR-497 and its variants and covers the composition of matter. Human hsa-miR-497 is an important component of the Company's miRview(TM) mets and mets2 diagnostic tests for the accurate identification of the tissue of origin in Cancers of Unknown Primary...

2011-04-12 06:50:00

PHILADELPHIA and REHOVOT, Israel, April 12, 2011 /PRNewswire/ -- Rosetta Genomics, Ltd. (Nasdaq: ROSG) today announced that the Company's Board of Directors has appointed Director Brian A. Markison, former Chairman and Chief Executive Officer of King Pharmaceuticals, as Rosetta's new Board Chairman, as current chairman, Yoav Z. Chelouche, has resigned from the Company's Board and from his role as its Chairman effective today. Mr. Chelouche continues to serve as the Chairman of Rosetta...

2011-04-02 01:45:44

Biomarkers help predict lung cancer patients whose disease could spread to the brain Conducting genetic profiles using microRNA can help doctors predict which lung cancer patients are likely to also develop brain metastasis (BM), according to a study published today by Scottsdale Healthcare and the Translational Genomics Research Institute (TGen). The study identified microRNA-328 as a potential therapeutic target because of its association with the spread of cancer to the brain in patients...

2011-03-29 07:30:00

FREMONT, Calif., March 29, 2011 /PRNewswire/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art genomic analysis systems, today announced data presentations from its recently announced industry-leading high-throughput SmartChip Human microRNA Panel V2 at three key scientific conferences. Researchers in the Oncology Division at Stanford University School of Medicine will present data obtained using the SmartChip Human microRNA Panel V2 in a...

2010-10-01 09:35:42

(Ivanhoe Newswire) "“ MircoRNA's are making the diagnosis and treatment of lung cancer faster and more precise. Lung cancers are traditionally divided into two main groups, either neuroendocrine or non-small cell lung cancer.  In 20 to 30 percent of the cases, making a definitive diagnosis of the tumor subtype using fine needle biopsy can be quite difficult.  Rosetta Genomics test, which is based on a panel of MicroRNAs, is going to make that 20 to 30 percent less difficult ....

2010-09-30 16:50:56

A test based on a panel of microRNAs under development by Rosetta Genomics, Ltd., in Rehovot, Israel, may allow for more precise diagnosis and better targeted therapy for patients with lung cancer. Tina B. Edmonston, M.D., director of the clinical laboratory at Rosetta Genomics, Inc., presented data on the assay at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development, held here. Lung cancers are traditionally divided into two main groups, either...

2010-08-10 07:00:00

HAYWARD, Calif., Aug. 10 /PRNewswire/ -- Advanced Cell Diagnostics, Inc. (ACD), announces the launch and immediate availability of RNAscope(TM) FFPE Assay Kit, a line of RUO (Research-Use-Only) products designed to detect RNA biomarkers in routine Formalin-Fixed, Paraffin-Embedded (FFPE) tissue specimens with single molecule sensitivity. The products are intended to be used by translational clinical researchers studying biomarkers in disease tissues and exploring their potential for...

2010-08-05 07:30:00

FREMONT, Calif., Aug. 5 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art genomic analysis systems, today announced it has launched the breakthrough WaferGen SmartChip Real-Time PCR System, the next-generation Real-Time PCR system for discovery and validation of biomarkers, or gene expression patterns, on a single platform. The SmartChip System is designed to provide accurate, highly sensitive and high-throughput gene...

2010-07-15 07:00:00

NEW YORK, July 15 /PRNewswire-FirstCall/ -- Rosetta Genomics (Nasdaq: ROSG) announces the following Webcast: What: LHA Life Sciences & Med Tech Day 2010 Presentation When: July 20, 2010 @ 9:30 AM Eastern http://www.investorcalendar.com/ Where: ClientPage.asp?ID=160317 Live over the Internet --Simply log on to the web at How: the address above. Contact: Cheryl Palazzo, 212-838-3777,...

2010-06-18 13:12:14

Virginia Commonwealth University researchers have discovered a mechanism by which an enzyme regulates gene expression and growth in melanoma cells, a finding that could someday lead to more effective drugs to attack cancers and make them more treatable. Melanoma, the most serious type of skin cancer, is highly resistant to current therapeutic strategies for reasons that are not well understood. New research at VCU suggests that an enzyme discovered in 2003 might be used to target a specific...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'